Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

7 reasons why DTC drug marketing will decline in 2013

Richard Meyer
Meds
March 30, 2013
Share
Tweet
Share

shutterstock_118348960

According to a new report from Cegedim Strategic Data, DTC promotional spending declined 22% versus last year. In fact they reported that “spending in nearly every channel saw decline year over year in 2012, the only exception being direct mail, which continued an upward trend.  Here are the reasons why I expect DTC marketing to continue to decline in 2013.

1. Most big brands are coming off patent. Pfizer is already looking for someone to spearhead the switch of Nexium to OTC and Lilly’s Cymbalta comes off patent next year.  The model of replacing “new and improved” versions of popular drugs is being challenged by payers who want clinical proof that it is better than generics.

2. Big pharma companies are getting squeezed by a changing healthcare environment. It not only costs more to develop and market new drugs the FDA often asks for more studies shortening the time the pharma company has exclusivity.

3. Changing demographics. We are seeing a changing of the guard as boomers turn 65 at the rate of about 10,000 per day.  Unlike previous generations Boomers challenge everything and want to make informed and educated decisions about healthcare. They still trust their doctors but want to know why and how before treatment.

4. Pharma ignores empowered patients. As my previous post indicated when it comes to digital marketing pharma is lagging way behind other industries and shows no signs of wanting to catch up by building digital marketing capabilities.  Patients are embracing the internet for health but pharma is stuck in a model of search marketing and websites with some digital ads here and there.  There is also a wide spread belief that digital marketing is less expensive that other marketing channels when we know that is not true.

5. Lack of talent. In case you haven’t noticed a lot of talented marketing people are leaving the pharma industry because legal and regulatory people have all but killed any attempt at two way marketing.  At the same time executives are asking for proof that DTC marketing works and want a direct connection between money spent and results.

6. TV is becoming more and more ineffective. If you believe that someone is going to see an ad for your product and run to their doctor to ask for it there is some swamp land I would like to sell you.  More and more people are multitasking while watching TV and they aren’t paying attention to your ads.

7. Consumers are smarter than DTC marketers. A great example are the stories recently about how some diabetes drugs can cause an pancreatic problems.  Where are the drug makers to explain and clarify this information ?

This has been coming for a long long time and unless DTC marketers wake up they are going to find budgets cuts even more severely.  Time to bring pharma marketing into the 21st century.

Richard Meyer is Executive Director/Principal at Online Strategic Solutions and blogs at World of DTC Marketing.com.

Image credit: Shutterstock.com

Prev

Make small bets during the era of health reform

March 29, 2013 Kevin 3
…
Next

It's our duty as physicians to avoid needless tests

March 30, 2013 Kevin 11
…

Tagged as: Medications

Post navigation

< Previous Post
Make small bets during the era of health reform
Next Post >
It's our duty as physicians to avoid needless tests

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

More by Richard Meyer

  • a desk with keyboard and ipad with the kevinmd logo

    Mobile health apps don’t always follow conventional wisdom

    Richard Meyer
  • a desk with keyboard and ipad with the kevinmd logo

    How can pharma earn the trust of patients?

    Richard Meyer
  • a desk with keyboard and ipad with the kevinmd logo

    Celebrity endorsements of prescription drugs

    Richard Meyer

More in Meds

  • Why retail pharmacies are the future of diverse clinical trials

    Shelli Pavone
  • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

    Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO
  • A world without antidepressants: What could possibly go wrong?

    Tomi Mitchell, MD
  • The truth about GLP-1 medications for weight loss: What every patient should know

    Nisha Kuruvadi, DO
  • The hidden bias in how we treat chronic pain

    Richard A. Lawhern, PhD
  • Biologics are not small molecules: the case for pre-allergy testing in an era of immune-based therapies

    Robert Trent
  • Most Popular

  • Past Week

    • 2 hours to decide my future: How the SOAP residency match traps future doctors

      Nicolette V. S. Sewall, MD, MPH | Education
    • Why removing fluoride from water is a public health disaster

      Steven J. Katz, DDS | Conditions
    • When did we start treating our lives like trauma?

      Maureen Gibbons, MD | Physician
    • In a fractured world, Brian Wilson’s message still heals

      Arthur Lazarus, MD, MBA | Physician
    • When your dream job becomes a nightmare [PODCAST]

      The Podcast by KevinMD | Podcast
    • How doctors took back control from hospital executives

      Gene Uzawa Dorio, MD | Physician
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • Why shared decision-making in medicine often fails

      M. Bennet Broner, PhD | Conditions
    • My journey from misdiagnosis to living fully with APBD

      Jeff Cooper | Conditions
    • Why we fear being forgotten more than death itself

      Patrick Hudson, MD | Physician
  • Recent Posts

    • When your dream job becomes a nightmare [PODCAST]

      The Podcast by KevinMD | Podcast
    • Finding healing in narrative medicine: When words replace silence

      Michele Luckenbaugh | Conditions
    • Why coaching is not a substitute for psychotherapy

      Maire Daugharty, MD | Conditions
    • When the white coats become gatekeepers: How a quiet cartel strangles America’s health

      Anonymous | Physician
    • Why doctors stay silent about preventable harm

      Jenny Shields, PhD | Conditions
    • Why interoperability is key to achieving the quintuple aim in health care

      Steven Lane, MD | Tech

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 6 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • 2 hours to decide my future: How the SOAP residency match traps future doctors

      Nicolette V. S. Sewall, MD, MPH | Education
    • Why removing fluoride from water is a public health disaster

      Steven J. Katz, DDS | Conditions
    • When did we start treating our lives like trauma?

      Maureen Gibbons, MD | Physician
    • In a fractured world, Brian Wilson’s message still heals

      Arthur Lazarus, MD, MBA | Physician
    • When your dream job becomes a nightmare [PODCAST]

      The Podcast by KevinMD | Podcast
    • How doctors took back control from hospital executives

      Gene Uzawa Dorio, MD | Physician
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • Why shared decision-making in medicine often fails

      M. Bennet Broner, PhD | Conditions
    • My journey from misdiagnosis to living fully with APBD

      Jeff Cooper | Conditions
    • Why we fear being forgotten more than death itself

      Patrick Hudson, MD | Physician
  • Recent Posts

    • When your dream job becomes a nightmare [PODCAST]

      The Podcast by KevinMD | Podcast
    • Finding healing in narrative medicine: When words replace silence

      Michele Luckenbaugh | Conditions
    • Why coaching is not a substitute for psychotherapy

      Maire Daugharty, MD | Conditions
    • When the white coats become gatekeepers: How a quiet cartel strangles America’s health

      Anonymous | Physician
    • Why doctors stay silent about preventable harm

      Jenny Shields, PhD | Conditions
    • Why interoperability is key to achieving the quintuple aim in health care

      Steven Lane, MD | Tech

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

7 reasons why DTC drug marketing will decline in 2013
6 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...